This HTML5 document contains 127 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n10http://dx.doi.org/10.1200/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33389767
rdf:type
wikibase:Item
schema:description
artikulong pang-agham ২০১০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ บทความทางวิทยาศาสตร์ scienca artikolo article scientifique (publié 2010) научни чланак 2010年论文 bài báo khoa học videnskabelig artikel (udgivet 2010) artigo científico (publicado na 2010) artículu científicu espublizáu en 2010 2010年論文 мақолаи илмӣ vitenskapelig artikkel научна статия 2010年论文 2010 nî lūn-bûn article científic vedecký článok 2010 թվականի մայիսին հրատարակված գիտական հոդված artykuł naukowy scientific article artikull shkencor מאמר מדעי 2010년 논문 επιστημονικό άρθρο articol științific 2010年論文 vitskapeleg artikkel naučni članak artigo científico mokslinis straipsnis 2010年论文 2010年论文 artículo científico publicado en 2010 vědecký článek научни чланак 2010年論文 мақолаи илмӣ tieteellinen artikkeli artigo científico (publicado na 2010) مقالة علمية مقالهٔ علمی bilimsel makale სამეცნიერო სტატია سائنسی مضمون articolo scientifico 2010年论文 2010年論文 teaduslik artikkel wissenschaftlicher Artikel 2010 թուականի Մայիսին հրատարակուած գիտական յօդուած wetenschappelijk artikel научная статья tudományos cikk 2010年论文 2010年論文 2010年の論文 наукова стаття, опублікована в травні 2010 vetenskaplig artikel article scientific
p:P577
wds:Q33389767-256098E4-8AB5-47A3-B491-8CCA150147A4
wdt:P577
2010-05-24T00:00:00Z
p:P407
wds:Q33389767-035AA56C-CB6D-4376-BEEC-7FF6D7467065
wdt:P407
wd:Q1860
p:P2093
wds:Q33389767-DA2EB924-28DB-451F-8D94-9CA8F067CBF6 wds:Q33389767-7C754FD1-CD6B-483F-B812-889C3E281DA9 wds:Q33389767-77717DF9-01C6-4540-91D1-5AF155F06EA6 wds:Q33389767-732D4838-5483-471E-9ED5-22CB354F413F wds:Q33389767-3CCC8B76-A92C-455F-8B39-9964B662A2D1 wds:Q33389767-4F387B24-CE1B-481C-BD4C-8B73E6370656 wds:Q33389767-2E14EF44-B305-41AA-B56A-8A0C488C3EBC wds:Q33389767-38A04C10-860D-44A7-BFE2-E68FAFECC714 wds:Q33389767-2A07632A-D88C-4C92-85B9-3686D4624BC9 wds:Q33389767-097A972B-B69A-48F0-9A6B-F75536670D4C
wdt:P2093
Bo Huang Ki Y Chung Jesus Gomez-Navarro Lawrence Fong Peggy J Criscitiello Ira Gore Diane I Healey Stephen B Beck Alan Venook Prudence Dorazio
rdfs:label
Phase II study of the anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody, tremelimumab, in patients with refractory metastatic colorectal cancer Phase II study of the anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody, tremelimumab, in patients with refractory metastatic colorectal cancer Phase II study of the anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody, tremelimumab, in patients with refractory metastatic colorectal cancer
skos:prefLabel
Phase II study of the anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody, tremelimumab, in patients with refractory metastatic colorectal cancer Phase II study of the anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody, tremelimumab, in patients with refractory metastatic colorectal cancer Phase II study of the anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody, tremelimumab, in patients with refractory metastatic colorectal cancer
schema:name
Phase II study of the anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody, tremelimumab, in patients with refractory metastatic colorectal cancer Phase II study of the anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody, tremelimumab, in patients with refractory metastatic colorectal cancer Phase II study of the anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody, tremelimumab, in patients with refractory metastatic colorectal cancer
p:P50
wds:Q33389767-72A74925-22D1-40B3-B44A-13D68AE0EF58
wdt:P50
wd:Q37830465
p:P1476
wds:Q33389767-E12369C9-65A6-47A4-8B00-6DBC264380D2
wdt:P1476
Phase II study of the anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody, tremelimumab, in patients with refractory metastatic colorectal cancer
p:P304
wds:Q33389767-8DC1EEC8-AAD5-4DFC-AA0C-97FA8E68548D
wdt:P304
3485-3490
p:P31
wds:Q33389767-5074FDA4-FE0C-413F-9CEC-9753A53ACAAA
wdt:P31
wd:Q13442814
p:P921
wds:Q33389767-18E62D2E-8195-451A-B73A-5941168491E9 wds:Q33389767-68C2DFC2-E7B1-4270-8645-D4701DC135F3 wds:Q33389767-96393C3D-1CAD-49AF-B690-A446F6C02BEC wds:Q33389767-98B2B42A-ACD2-4277-AB1B-257F5F4DB099 wds:Q33389767-A2FD00E1-D67F-464D-B390-6A69FE26F3D4 wds:Q33389767-F0180397-4D43-4356-BB0C-0985998DDF47
wdt:P921
wd:Q246181 wd:Q79460 wd:Q25493920 wd:Q188874 wd:Q422248 wd:Q181600
p:P698
wds:Q33389767-7BA7D97D-3392-42D5-B796-A76C4E913E48
wdtn:P698
n12:20498386
wdt:P698
20498386
p:P1433
wds:Q33389767-B79A835B-0BD4-4209-AE5D-9D7B7C3EC89D
wdt:P1433
wd:Q400292
p:P433
wds:Q33389767-AD88BB36-61FC-4DE1-BABB-24E60FC2A7B8
p:P478
wds:Q33389767-22DA0365-91E4-497A-AE34-D8497B108E1D
wdt:P433
21
wdt:P478
28
p:P356
wds:Q33389767-D4AD3F8B-0A0B-48F6-BBCE-EEE56E252770
wdtn:P356
n10:JCO.2010.28.3994
wdt:P356
10.1200/JCO.2010.28.3994